Cepharanthine inhibits lysosomes and induces apoptosis in triple‑negative breast cancer cells. [PDF]
Li J +5 more
europepmc +1 more source
Theratyping as a tool to guide clinical decision-making in patients with suspected cystic fibrosis and variants currently ineligible for CFTR modulator therapy. [PDF]
Gannon RM +10 more
europepmc +1 more source
Reply to Piehler et al.: Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy. [PDF]
Duff AJA, Lee TWR.
europepmc +1 more source
Fyn-Saracatinib Complex Structure Reveals an Active State-like Conformation. [PDF]
Ta HM +5 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis. [PDF]
Kümmerli S +6 more
europepmc +1 more source
Piperine protects ovarian follicles and stromal cells against doxorubicin-induced adverse effects in mouse ovaries. [PDF]
Rocha MBM +10 more
europepmc +1 more source
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy. [PDF]
Green N +14 more
europepmc +1 more source
Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis. [PDF]
Geiger JM +6 more
europepmc +1 more source
Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and Inflammation. [PDF]
Ludovico A, Battistini M, Baroni D.
europepmc +1 more source

